2-138552628-C-T
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BP4
The NM_001001664.3(SPOPL):c.427C>T(p.Leu143Phe) variant causes a missense change. The variant allele was found at a frequency of 0.0000217 in 1,613,016 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.00011 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000013 ( 0 hom. )
Consequence
SPOPL
NM_001001664.3 missense
NM_001001664.3 missense
Scores
3
6
9
Clinical Significance
Conservation
PhyloP100: 5.05
Genes affected
SPOPL (HGNC:27934): (speckle type BTB/POZ protein like) Predicted to enable ubiquitin protein ligase binding activity. Involved in negative regulation of protein ubiquitination and proteasome-mediated ubiquitin-dependent protein catabolic process. Part of Cul3-RING ubiquitin ligase complex. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 1 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.4022957).
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SPOPL | NM_001001664.3 | c.427C>T | p.Leu143Phe | missense_variant | 5/11 | ENST00000280098.9 | NP_001001664.1 | |
SPOPL | XM_047444115.1 | c.105C>T | p.Cys35Cys | synonymous_variant | 3/10 | XP_047300071.1 | ||
SPOPL | XM_047444116.1 | c.105C>T | p.Cys35Cys | synonymous_variant | 3/10 | XP_047300072.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SPOPL | ENST00000280098.9 | c.427C>T | p.Leu143Phe | missense_variant | 5/11 | 1 | NM_001001664.3 | ENSP00000280098.4 | ||
SPOPL | ENST00000420679.1 | n.427C>T | non_coding_transcript_exon_variant | 4/11 | 5 | ENSP00000396006.1 | ||||
SPOPL | ENST00000430968.5 | n.*137C>T | downstream_gene_variant | 5 | ENSP00000410201.1 |
Frequencies
GnomAD3 genomes AF: 0.000105 AC: 16AN: 151990Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
16
AN:
151990
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000199 AC: 5AN: 250834Hom.: 0 AF XY: 0.0000147 AC XY: 2AN XY: 135612
GnomAD3 exomes
AF:
AC:
5
AN:
250834
Hom.:
AF XY:
AC XY:
2
AN XY:
135612
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000130 AC: 19AN: 1460908Hom.: 0 Cov.: 30 AF XY: 0.00000963 AC XY: 7AN XY: 726774
GnomAD4 exome
AF:
AC:
19
AN:
1460908
Hom.:
Cov.:
30
AF XY:
AC XY:
7
AN XY:
726774
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000105 AC: 16AN: 152108Hom.: 0 Cov.: 32 AF XY: 0.000108 AC XY: 8AN XY: 74370
GnomAD4 genome
AF:
AC:
16
AN:
152108
Hom.:
Cov.:
32
AF XY:
AC XY:
8
AN XY:
74370
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ExAC
AF:
AC:
6
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 22, 2022 | The c.427C>T (p.L143F) alteration is located in exon 5 (coding exon 4) of the SPOPL gene. This alteration results from a C to T substitution at nucleotide position 427, causing the leucine (L) at amino acid position 143 to be replaced by a phenylalanine (F). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Uncertain
D
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Uncertain
D
LIST_S2
Pathogenic
D
M_CAP
Benign
T
MetaRNN
Benign
T
MetaSVM
Benign
T
PrimateAI
Pathogenic
D
PROVEAN
Uncertain
D
REVEL
Benign
Sift
Benign
D
Sift4G
Benign
T
Polyphen
D
Vest4
MVP
MPC
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at